We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer.
- Authors
Soloway, Mark S.; Ikard, Melinda; Ford, Kimball; Soloway, M S; Ikard, M; Ford, K
- Abstract
Twenty-seven consecutive patients with locally extensive or metastatic urothelial cancer, primarily bladder, were given cis-diamminedichloroplatinum (II) (DDP) at a dose of 70 mg/m2 every three weeks. All patients had hydration and mannitol-induced diuresis initiated before administration of DDP. Nine patients (33%) had a partial response; 12 (45%) remained stable for an average duration of six months. Responders had a significantly greater survival than nonresponders. Although severe nephrotoxicity did not occur, patients with either a solitary or obstructed kidney were at greater risk of an increase in the serum creatinine during therapy.
- Publication
Cancer (0008543X), 1981, Vol 47, Issue 3, p476
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/1097-0142(19810201)47:3<476::AID-CNCR2820470309>3.0.CO;2-8